Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Bohle A, Müller GA, Wehrmann M, Mackensen-Haen S, Xiao JC. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl. 1996;54:S2-9.
2. Bullen AL, Katz R, Jotwani V, Garimella PS, Lee AK, Estrella MM, et al. Biomarkers of kidney tubule health, CKD progression, and acute kidney injury in SPRINT (Systolic Blood Pressure Intervention Trial) participants. Am J Kidney Dis. 2021;78:361-8.e1.
3. Singh SS, Chauhan SB, Kumar A, Kumar S, Engwerda CR, Sundar S, et al. Amphiregulin in cellular physiology, health, and disease: potential use as a biomarker and therapeutic target. J Cell Physiol. 2022;237:1143–56.
4. Zaiss DMW. Amphiregulin as a driver of tissue fibrosis. Am J Transplant. 2020;20:631–2.
5. Kefaloyianni E, Raja MR, Schumacher J, Muthu ML, Krishnadoss V, Waikar SS, et al. Proximal tubule-derived amphiregulin amplifies and integrates profibrotic EGF receptor signals in kidney fibrosis. J Am Soc Nephrol. 2019;30:2370–83.